← All trials
NCT04523090
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 27, 2020
- Primary completion
- Apr 30, 2021
- Completion date
- Aug 31, 2021
- First posted
- Aug 21, 2020
- Last posted
- Sep 1, 2020
- Enrollment
- 960
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Cape TownLead sponsor
- Texas Tech UniversityCollaborator
- University of Kwa-Zulu NatalCollaborator
- National Institutes of Health (NIH)Collaborator
- Aurum InstituteCollaborator
- University of Cape TownReponsible party - principal investigator
- Medical Research Council, South AfricaCollaborator
- University of the WitwatersrandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.